Serum Institute seeks emergency use authorisation for Oxford Covid-19 vaccine Covishield in India

Serum Institute seeks emergency use authorisation for Oxford Covid-19 vaccine Covishield in India A day earlier, the Indian arm of US pharmaceutical giant Pfizer became the first to seek a similar approval from India's drug regulator for its own Covid-19 vaccine in the country, after securing such clearance in the UK and Bahrain. https://ift.tt/eA8V8J